A foreign medicine manufacturer may have an approved product, strong manufacturing systems and an Indian business partner ready to distribute it. But none of that guarantees a smooth Indian market entry. Before commercial import begins, the product, overseas manufacturing site and Indian applicant must be assessed through the appropriate regulatory route.
A CDSCO drugs import licence supports the lawful import of eligible bulk drugs and finished formulations into India. It is generally connected with two important approvals: the Registration Certificate in Form 41 and the Import Licence in Form 10 or Form 10A, depending on the product category. CDSCO confirms that applications for these approvals are submitted online through the SUGAM system by an authorised Indian agent or eligible foreign manufacturer.
This process is more than a formality. It brings together the foreign manufacturer, Indian authorised agent, product dossier, manufacturing site, labelling information and post-import responsibilities.
What Is CDSCO?
CDSCO stands for the Central Drugs Standard Control Organisation. It is India’s national regulatory authority for matters relating to drugs, cosmetics and certain other regulated healthcare products.
CDSCO’s responsibilities may include:
Import regulation.
New drug approvals.
Clinical trial permissions.
Standards and quality control.
Coordination with state drug authorities.
Registration of foreign manufacturing premises.
Licensing of imported drug products.
Regulatory oversight of selected medical and healthcare products.
The Drugs and Cosmetics Act, 1940 and the Drugs and Cosmetics Rules, 1945 provide the core legal framework for drug import and regulation in India. The applicable route may vary depending on whether the product is a bulk drug, finished formulation, Schedule X drug, new drug, biological product or another regulated category.
What Is a CDSCO Drugs Import Licence?
A CDSCO import licence permits the import of approved drug products into India subject to the conditions attached to the licence.
The process generally includes:
Registration of the foreign manufacturing premises and proposed products.
Submission of technical and regulatory documents.
Review by the competent authority.
Resolution of queries, if raised.
Grant of the applicable import licence.
Compliance with labelling, storage, distribution and recordkeeping requirements.
The CDSCO drugs import licence is not a substitute for every other approval a business may need. An importer may also need a wholesale drug licence, Import-Export Code, tax registrations, product-specific permissions and appropriate distribution arrangements.
Form 41, Form 10 and Form 10A
Understanding the forms is essential because each serves a different purpose.
Form 41: Registration Certificate
Form 41 is used for registering the foreign manufacturing premises and the drugs intended for import into India. It connects the overseas manufacturer and specified products with the Indian import process.
The registration should accurately identify:
The overseas manufacturer.
Manufacturing premises.
Product names.
Strength and dosage form.
Pack sizes.
Manufacturing and quality information.
Indian authorised agent.
Form 10: Import Licence
Form 10 is generally used for importing drugs other than those specified in Schedule X. It is connected with the products covered by the relevant registration and approved scope.
Form 10A: Schedule X Import Licence
Form 10A applies to drugs specified in Schedule X. Schedule X products may involve additional controls because of their regulated nature.
The applicant should not select a form only because it appears familiar. The product category should be assessed first. CDSCO’s published material distinguishes Form 10 for drugs excluding Schedule X and Form 10A for Schedule X drugs.
Who Can Apply?
The application may generally be submitted by:
An Indian authorised agent of the foreign manufacturer.
An Indian pharmaceutical company.
An Indian importer or distributor.
A subsidiary or joint venture of the foreign manufacturer.
A contract manufacturing or pharmaceutical organisation, where applicable.
A foreign manufacturer that meets the applicable requirements.
The Indian authorised agent plays an important role. This person or organisation communicates with CDSCO, coordinates documents, responds to queries and supports post-approval activities.
The agent should be capable of understanding the product and maintaining communication with the overseas manufacturer. A weak communication structure can lead to missed queries, inconsistent information and unnecessary delays.
Products That May Require CDSCO Import Approval
The requirement depends on the product and its regulatory classification. Common categories may include:
Finished pharmaceutical formulations.
Bulk drug substances.
Antibiotics.
Cardiovascular medicines.
Anti-diabetic medicines.
Vaccines.
Biological products.
Oncology medicines.
Hormonal preparations.
Dermatological medicines.
Injectable products.
Intravenous fluids.
Specialised therapeutic products.
Certain Schedule X medicines.
A product should be reviewed individually. Two products with similar names may be subject to different requirements because of their composition, dosage form, therapeutic claim or regulatory status.
The applicant should also check whether the product is considered a new drug or requires additional approval before applying for import licensing.
Key Eligibility Considerations
Before filing, the applicant should confirm:
The foreign manufacturer is legally established.
The manufacturing site is clearly identified.
The product is legally permitted for import.
The Indian authorised agent is properly appointed.
The relevant product approval pathway is understood.
The overseas site follows appropriate manufacturing standards.
Product specifications and test methods are available.
Indian labelling requirements can be met.
The Indian importer has the required business registrations.
The distribution and storage system is ready.
The applicant should also confirm that the product is not banned, misbranded, adulterated, spurious or otherwise prohibited.
Documents Usually Required
The exact documents depend on the product, manufacturer and application route. A typical regulatory file may include:
Application forms and declarations.
Manufacturer incorporation or registration documents.
Manufacturing licence from the country of origin.
Wholesale or sale licence, where applicable.
Certificate of Pharmaceutical Product.
Free Sale Certificate.
Good Manufacturing Practices certificate.
Site Master File.
Drug Master File.
Product Information Sheet.
Product specifications.
Test methods.
Stability data.
Safety and efficacy information.
Label and package artwork.
Package insert.
Manufacturing process details.
Power of attorney.
Authorisation letter for the Indian agent.
Indian importer’s PAN and GST details.
Import-Export Code.
Fee payment proof.
Undertakings and declarations.
The documents should be current, readable and consistent. The product name, manufacturer name, manufacturing site and dosage information should match throughout the submission.
For example, if the product is called “ABC-500 Tablets” in the Free Sale Certificate but “ABC Tablets 500 mg” in the package insert, the reviewer may request clarification.
How to Apply Through SUGAM
The CDSCO import licence application is generally submitted online through the SUGAM portal.
A practical process includes the following stages.
Step 1: Classify the product
Determine whether the product is a bulk drug, finished formulation, Schedule X medicine, biological, new drug or another regulated category.
Step 2: Confirm the applicant
Identify the Indian authorised agent or eligible applicant responsible for communication and filing.
Step 3: Prepare the regulatory dossier
Collect manufacturer, product, quality, safety, efficacy, labelling and legal documents.
Step 4: Create the SUGAM account
Register the applicant and complete the organisation profile with accurate information.
Step 5: Select the applicable service
Choose the relevant registration or import licence application based on the product.
Step 6: Upload the documents
Submit the forms and supporting records in the required format.
Step 7: Pay the prescribed fee
Complete the payment and preserve the receipt or transaction details.
Step 8: Respond to queries
CDSCO may raise questions or request additional information. Responses should be complete, consistent and submitted within the required period.
Step 9: Receive the approval
After satisfactory review, the applicable certificate or licence may be issued through the online system.
Step 10: Prepare for import
Coordinate the certificate, customs documentation, labels, shipping records and distribution arrangements before the first shipment.
Labelling and Packaging
Imported medicines must comply with applicable Indian labelling and packaging requirements. The label and package insert should be reviewed before final production.
Check:
Product name.
Generic name.
Strength.
Dosage form.
Batch number.
Manufacturing date.
Expiry date.
Manufacturing licence information.
Importer details.
Storage conditions.
Maximum retail price, where applicable.
Warning statements.
Schedule classification.
Pack size.
Country of origin.
Required declarations.
A label designed for another country may not automatically satisfy Indian requirements. The artwork should be reviewed early, particularly when the manufacturer wants to use the same packaging for multiple markets.
Importer and Wholesale Licence
A CDSCO approval does not always replace the importer’s state-level wholesale drug licence. A business importing and distributing medicines may need both central-level product or import approvals and state-level sale or storage permissions.
The importer should verify:
Whether a wholesale licence is required.
Whether the warehouse is licensed.
Whether the responsible person is appointed.
Whether temperature conditions are documented.
Whether stock and batch records are maintained.
Whether customers are authorised to purchase the products.
This coordination is important because a product may be approved for import but still face operational problems if the Indian distributor is not ready to store and supply it lawfully.
Post-Approval Responsibilities
After receiving the licence, the business must continue meeting the applicable conditions.
Important responsibilities may include:
Importing only approved products.
Maintaining accurate import and stock records.
Following approved labelling requirements.
Storing products under suitable conditions.
Monitoring batches and expiry dates.
Maintaining manufacturer quality documents.
Reporting relevant changes.
Handling complaints and recalls.
Cooperating with inspections.
Maintaining GMP-related information.
Completing renewal or retention requirements.
Applying for product inclusion or amendments where necessary.
If the foreign manufacturer changes its manufacturing site, product composition, packaging, legal name or authorised agent, the effect on the licence should be reviewed before the change is implemented.
Common Reasons for Delay
Applicants often experience delays because of:
Incomplete technical documents.
Incorrect product classification.
Missing manufacturer authorisation.
Outdated GMP certificate.
Inconsistent product names.
Poor-quality labels.
Missing stability or safety data.
Unclear manufacturing-site information.
Incorrect forms.
Weak communication with the foreign manufacturer.
Late responses to CDSCO queries.
Failure to coordinate the Indian wholesale licence.
A regulatory gap assessment before filing can identify many of these issues.
How Agile Regulatory Can Help
Agile Regulatory supports foreign manufacturers, Indian importers and pharmaceutical distributors with practical CDSCO guidance.
Our assistance may include:
Product-category assessment.
Import-route review.
Form 41, Form 10 and Form 10A guidance.
Indian authorised-agent coordination.
Regulatory dossier preparation.
Manufacturer-document review.
Label and package-insert review.
SUGAM portal application support.
CDSCO query response assistance.
Importer and wholesale-licence coordination.
Amendment and post-approval support.
Renewal and retention planning.
Our goal is to help businesses understand what is required before filing, reduce documentation gaps and build a workable compliance process for continuing imports.
Conclusion
A successful pharmaceutical import business needs more than a foreign product and an Indian buyer. It requires a carefully prepared regulatory pathway covering the manufacturer, product, authorised agent, import licence, labelling and post-import controls.
Agile Regulatory helps businesses manage Drug license requirements from initial product assessment to documentation, SUGAM filing, query resolution and post-approval support. Our team helps create a clearer route for foreign manufacturers and Indian importers planning to enter or expand in the Indian market.
If you are planning to import finished formulations, bulk drugs, biological products or other regulated pharmaceutical products, contact Agile Regulatory for a product-specific CDSCO assessment.
Frequently Asked Questions
1. What is the difference between Form 41 and Form 10?
Form 41 is generally the Registration Certificate for the foreign manufacturing premises and the drugs intended for import. Form 10 is generally the import licence for drugs excluding those specified in Schedule X.
2. When is Form 10A required?
Form 10A is generally associated with the import of drugs specified in Schedule X. The product should be classified correctly before selecting the application form.
3. Who can submit the CDSCO import application?
The application may generally be submitted by the local authorised agent of the foreign manufacturer or another eligible applicant through the SUGAM online system. CDSCO identifies the local authorised agent as a route for applying on behalf of a foreign manufacturer.
4. Is a wholesale drug licence also required?
A business importing and distributing medicines may need a state-level wholesale drug licence in addition to the central CDSCO import approval. The exact requirement depends on the business activity, state and product category.
5. What documents are important for a CDSCO import application?
Important documents may include the foreign manufacturing licence, GMP certificate, Certificate of Pharmaceutical Product or Free Sale Certificate, product information, labels, package inserts, technical data, manufacturer authorisation and Indian importer information.
6. Can Agile Regulatory help with CDSCO import licensing?
Yes. Agile Regulatory can assist with product classification, document preparation, authorised-agent coordination, Form 41 and Form 10/10A guidance, SUGAM filing, query resolution and post-licence compliance.
7. How long does the process take?
The timeline depends on the product category, completeness of the dossier, review requirements and time taken to answer queries. Products requiring additional assessment may take longer than straightforward applications.
Note: CDSCO forms, fees, documentation, portal procedures and product-specific requirements may change. Confirm the current requirements for the exact medicine and manufacturing site before filing an application or arranging commercial import.
Comments
Log in or sign up to join the conversation.